JD HEALTH
06618
TRIP.COM-S
09961
XIAOMI-W
01810
KUAISHOU-W
01024
BEKE-W
02423
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Inventory | -12.12%21.42B | -8.71%22.36B | -9.40%23.37B | -13.96%21.13B | -5.17%24.37B | -5.63%24.49B | 3.90%25.8B | 14.56%24.56B | 4.89%25.7B | 6.21%25.95B |
Accounts receivable | -4.12%56.14B | -1.20%91.27B | -0.72%53.18B | -6.34%81.9B | 2.16%58.55B | 1.35%92.38B | 0.74%53.57B | -0.22%87.44B | -3.18%57.31B | -14.11%91.15B |
Notes receivable | 6.28%1.01B | ---- | -29.22%1.54B | ---- | -10.65%954.7M | ---- | 241.72%2.18B | ---- | -32.51%1.07B | ---- |
Related party payments receivable | ---- | -34.88%2.18B | ---- | 18.73%3.27B | ---- | 55.85%3.35B | ---- | 16.63%2.75B | ---- | 18.43%2.15B |
Advance deposits and other receivables | -8.07%9.41B | ---- | -13.08%9.97B | ---- | -3.81%10.23B | ---- | -1.45%11.47B | ---- | -28.27%10.64B | ---- |
Cash and equivalents | -21.79%27.44B | -23.72%24.81B | -9.18%32.8B | 1.63%27.43B | -17.98%35.09B | -13.89%32.52B | --36.12B | -1.53%26.99B | 10.29%42.79B | 40.09%37.77B |
Secured deposit | ---- | -2.32%3.75B | ---- | 13.11%4.84B | ---- | -3.50%3.84B | ---- | 9.65%4.28B | ---- | -39.98%3.98B |
Financial assets at fair value-current assets | -0.15%10.14B | -7.30%6.51B | -9.63%9.4B | 23.14%9.93B | 16.79%10.16B | 11.82%7.02B | -78.78%10.4B | -2.33%8.07B | 18.09%8.7B | 28.87%6.28B |
Derivative financial instruments-current assets | ---- | -65.30%4.69M | ---- | -94.79%1.46M | ---- | 1,601.01%13.52M | ---- | 69.31%28.07M | ---- | -84.08%795K |
Other current assets | 46.67%4.14B | ---- | 63.14%4.3B | ---- | 48.88%2.82B | ---- | -14.11%2.63B | ---- | -39.48%1.9B | ---- |
Special items of current assets | 30.75%1.57B | ---- | 10.06%1.53B | ---- | -0.58%1.2B | ---- | 24.32%1.39B | ---- | 26.09%1.21B | -88.76%7.86M |
Total current assets | -7.57%152.58B | -7.78%150.89B | -5.24%156.97B | -3.64%148.5B | -4.38%165.08B | -2.19%163.62B | -2.54%165.64B | 2.05%154.11B | -5.17%172.65B | -2.12%167.29B |
Non-current assets | ||||||||||
Fixed assets | -2.31%168.81B | ---- | -0.66%171.71B | ---- | 3.29%172.81B | ---- | 3.64%172.86B | ---- | 2.49%167.3B | ---- |
Property, plant and equipment | ---- | 2.68%203.1B | ---- | 1.64%198.01B | ---- | 6.11%197.8B | ---- | 7.42%194.82B | ---- | 2.68%186.41B |
Investment property | 26.52%1.84B | 26.86%1.86B | 27.72%1.87B | 8.63%1.61B | -0.06%1.46B | 31.63%1.47B | 46.86%1.47B | 53.77%1.48B | 83.80%1.46B | 35.75%1.11B |
Construction in progress | 20.93%34.19B | ---- | 22.55%28.51B | ---- | 24.55%28.27B | ---- | 38.15%23.26B | ---- | -9.61%22.7B | ---- |
Advance payment | ---- | -18.02%1.83B | ---- | -32.05%1.74B | ---- | -49.36%2.23B | ---- | -35.85%2.56B | ---- | -17.62%4.41B |
Long-term receivables | -4.34%3.68B | -12.00%4.43B | 1.45%4.19B | 14.34%4.69B | 18.52%3.84B | 93.63%5.04B | 16.18%4.13B | 13.69%4.1B | -48.13%3.24B | -77.49%2.6B |
Development expenditure | -37.33%227.31M | ---- | -17.77%272.37M | ---- | 18.05%362.7M | ---- | 74.22%331.23M | ---- | -39.93%307.25M | ---- |
Associated company interest | ---- | 8.26%32.65B | ---- | 9.44%32.75B | ---- | 6.66%30.16B | ---- | 11.51%29.93B | ---- | 33.39%28.27B |
Interests in Joint Venture | ---- | 1.61%226.08M | ---- | 84.24%233.07M | ---- | 71.61%222.51M | ---- | -3.69%126.5M | ---- | 12.50%129.66M |
long-term investment | 6.71%33.18B | ---- | 8.46%33.24B | ---- | 3.78%31.09B | ---- | 10.15%30.65B | ---- | 31.19%29.96B | ---- |
Financial assets at fair value-non-current assets | ---- | -2.58%3.48B | ---- | -2.85%3.77B | ---- | 84.35%3.58B | ---- | 53.59%3.88B | ---- | -16.21%1.94B |
Derivative financial instruments-non-current assets | ---- | ---- | ---- | 105.86%7.17M | ---- | --1.96M | ---- | --3.48M | ---- | ---- |
Intangible assets | 2.43%52.83B | 1.07%30.8B | 3.22%52.12B | 3.25%29.88B | 10.48%51.58B | 15.64%30.48B | 9.87%50.49B | 13.04%28.94B | 6.74%46.69B | 11.42%26.36B |
Goodwill | 5.87%34.45B | 5.53%34.5B | 5.10%34.17B | -1.20%32.24B | 0.71%32.54B | 1.08%32.69B | 0.76%32.52B | 0.96%32.63B | -7.96%32.31B | -8.28%32.34B |
Deferred tax assets | 10.51%8.52B | 12.99%8.79B | 12.15%8.56B | 10.84%8.44B | 13.80%7.71B | 16.96%7.78B | 25.88%7.63B | 20.91%7.61B | 16.14%6.78B | 7.05%6.65B |
Other illiquid assets | -37.54%2.61B | ---- | -23.98%2.75B | ---- | -1.74%4.17B | ---- | -26.19%3.62B | ---- | -62.03%4.25B | ---- |
Special items of non-current assets | -9.80%5.78B | ---- | -0.68%6B | ---- | 12.54%6.41B | ---- | 16.78%6.04B | ---- | 44.33%5.7B | ---- |
Total non-current assets | 1.82%349.24B | 2.59%348.79B | 3.16%346.27B | 1.54%340.39B | 6.19%342.98B | 6.72%339.99B | 7.12%335.65B | 7.11%335.23B | 0.54%322.99B | 0.17%318.57B |
Total assets | -1.23%501.81B | -0.78%499.67B | 0.39%503.24B | -0.09%488.9B | 2.51%508.06B | 3.65%503.61B | 3.72%501.29B | 5.46%489.34B | -1.53%495.63B | -0.63%485.86B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Accounts payable | -4.79%48.61B | -4.59%95.48B | -6.59%47.7B | -7.80%93.78B | 13.08%51.06B | 2.66%100.07B | 21.79%51.07B | 3.03%101.72B | -12.33%45.15B | -9.48%97.48B |
Notes payable | -7.68%16.27B | ---- | -12.68%15.73B | ---- | -15.09%17.62B | ---- | -15.49%18.01B | ---- | -3.61%20.75B | ---- |
Tax payable | -6.66%2.54B | -36.92%1.01B | -27.81%2.18B | -30.18%1.54B | -39.02%2.72B | -32.62%1.61B | -34.15%3.02B | -44.80%2.21B | -10.86%4.46B | -35.31%2.39B |
Dividend payable | ---- | -62.76%289.44M | ---- | -52.68%480.6M | ---- | 9.76%777.17M | ---- | -22.05%1.02B | ---- | -16.92%708.04M |
Amounts payable to associated parties-current liabilities | ---- | -2.47%5.85B | ---- | 9.34%6.61B | ---- | 38.70%6B | ---- | 18.84%6.05B | ---- | 0.00%4.33B |
Other payables and accrued expenses | 1.74%15.75B | ---- | 5.83%15.47B | ---- | 4.93%15.48B | ---- | -14.40%14.62B | ---- | -28.09%14.75B | ---- |
Advance payment | 114.82%144.35M | ---- | 7,836.47%221.76M | ---- | 5,211.31%67.2M | ---- | 1,460.53%2.79M | ---- | --1.27M | ---- |
Short-term borrowing | -11.98%35.37B | ---- | -11.01%39.24B | ---- | -33.10%40.19B | ---- | -21.72%44.09B | ---- | 1.13%60.07B | ---- |
Bank loans and overdrafts | ---- | 1.14%78.57B | ---- | -4.77%73.98B | ---- | -21.65%77.68B | ---- | 5.07%77.69B | ---- | 4.91%99.15B |
Derivative financial instrument-current liabilities | ---- | -81.60%19.19M | ---- | 232.39%72.53M | ---- | 1,237.58%104.28M | ---- | 193.54%21.82M | ---- | -40.76%7.8M |
Financial lease liabilities-current liabilities | ---- | 12.65%300.93M | ---- | -23.74%291.31M | ---- | -78.39%267.14M | ---- | -13.66%382M | ---- | 143.68%1.24B |
Other current liabilities | 15.87%5.08B | ---- | 19.74%7.77B | ---- | -52.40%4.38B | ---- | -2.33%6.49B | ---- | 35.14%9.2B | ---- |
Special items of current liabilities | -16.27%28.69B | ---- | 14.27%33.04B | ---- | 25.76%34.26B | ---- | 21.28%28.91B | ---- | -25.73%27.24B | ---- |
Total current liabilities | -7.66%165.96B | -2.68%181.54B | -3.26%173.04B | -6.54%176.8B | -8.47%179.73B | -9.14%186.54B | -3.03%178.88B | 3.05%189.16B | -10.13%196.37B | -2.96%205.31B |
Net current assets | 8.69%-13.38B | -33.72%-30.65B | -21.39%-16.07B | 19.27%-28.29B | 38.23%-14.66B | 39.72%-22.92B | 8.80%-13.24B | -7.71%-35.04B | 34.88%-23.73B | 6.49%-38.02B |
Total assets less current liabilities | 2.29%335.85B | 0.34%318.14B | 2.42%330.2B | 3.97%312.1B | 9.71%328.33B | 13.02%317.07B | 7.89%322.41B | 7.04%300.19B | 5.07%299.26B | 1.15%280.55B |
Non-current liabilities | ||||||||||
Long-term bank loan | 18.31%108.27B | 3.79%120.16B | 33.19%108.09B | 14.89%110.93B | 58.46%91.52B | 34.32%115.78B | 43.08%81.15B | 3.61%96.55B | 3.76%57.75B | -6.65%86.19B |
Long-term accounts payable | -16.91%3.39B | ---- | 6.41%3.37B | ---- | 6.27%4.07B | ---- | -44.31%3.17B | ---- | -14.58%3.83B | ---- |
Long-term remuneration payable to staff and workers | -32.56%342.53M | -28.09%317.47M | -33.55%343.47M | -28.81%303.8M | 50.43%507.94M | 109.94%441.47M | 46.31%516.92M | 96.64%426.77M | -6.85%337.65M | -8.96%210.28M |
Financial lease liabilities-non-current liabilities | 13.65%2.13B | 25.40%2.2B | 24.52%2.09B | 0.06%1.83B | 28.73%1.88B | 9.03%1.75B | 8.65%1.68B | -28.61%1.83B | -11.38%1.46B | -37.96%1.61B |
Deferred tax liability | 20.30%3.28B | 28.28%3.51B | 11.97%3.37B | 10.12%3.29B | 1.34%2.73B | -5.08%2.74B | 7.15%3.01B | 1.22%2.99B | 2.94%2.69B | -3.27%2.88B |
Deferred income-non-current liabilities | 1.24%2.16B | -5.64%2.2B | -5.58%2.08B | -6.91%2.23B | -0.70%2.13B | 5.59%2.33B | 16.05%2.2B | 6.82%2.4B | 16.16%2.14B | -0.05%2.2B |
Derivative financial instruments-non-current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.94M | ---- | ---- |
Other non-current liabilities | -89.66%12.91M | ---- | 611.21%10.66M | ---- | -26.10%124.88M | ---- | -99.17%1.5M | ---- | -35.65%168.98M | ---- |
Special items of non-current liabilities | 1.53%25.48B | ---- | -51.32%17.3B | ---- | -34.45%25.1B | ---- | -19.27%35.53B | ---- | 7.03%38.28B | ---- |
Total non-current liabilities | 13.29%145.06B | 4.35%128.38B | 7.38%136.65B | 13.81%118.59B | 20.04%128.05B | 32.16%123.03B | 12.42%127.26B | 2.99%104.2B | 3.92%106.67B | -7.22%93.09B |
Total liabilities | 1.05%311.02B | 0.11%309.91B | 1.16%309.69B | 0.69%295.38B | 1.56%307.79B | 3.74%309.57B | 2.85%306.14B | 3.03%293.36B | -5.64%303.05B | -4.33%298.41B |
Total assets less total liabilities | -4.74%190.79B | -2.21%189.76B | -0.82%193.55B | -1.26%193.51B | 3.99%200.27B | 3.51%194.04B | 5.13%195.15B | 9.32%195.99B | 5.72%192.59B | 5.89%187.46B |
Total equity and non-current liabilities | 2.29%335.85B | 0.34%318.14B | 2.42%330.2B | 3.97%312.1B | 9.71%328.33B | 13.02%317.07B | 7.89%322.41B | 7.04%300.19B | 5.07%299.26B | 1.15%280.55B |
Equity | ||||||||||
Share capital | 0.00%8.43B | 0.00%8.43B | 0.00%8.43B | 0.00%8.43B | 0.00%8.43B | 0.00%8.43B | 0.00%8.43B | 0.00%8.43B | 0.00%8.43B | 0.00%8.43B |
Other equity instruments | -14.42%16.55B | 15.15%17.86B | 12.89%17.55B | 12.76%17.84B | -8.03%19.34B | -20.15%15.51B | -8.76%15.55B | -5.88%15.82B | 7.68%21.03B | -1.94%19.42B |
Reserve | ---- | -6.46%90.45B | ---- | -2.03%96.89B | ---- | 2.12%96.71B | ---- | 5.23%98.89B | ---- | 9.95%94.69B |
Capital reserve | -30.57%9.93B | ---- | -11.53%12.64B | ---- | 0.66%14.3B | ---- | 2.63%14.29B | ---- | -7.07%14.21B | ---- |
Undistributed profit | -1.75%75.03B | ---- | -0.33%76.68B | ---- | 1.22%76.37B | ---- | 0.90%76.93B | ---- | 2.16%75.45B | ---- |
Special items of shareholders' rights and interests | -2.68%913.56M | -15.15%-17.86B | -0.81%838.68M | -12.76%-17.84B | 4.74%938.72M | 20.15%-15.51B | 3.24%845.56M | 5.88%-15.82B | 23.47%896.2M | 1.94%-19.42B |
Shareholders' Equity | -6.90%116.58B | -5.95%98.89B | 0.01%121.88B | -1.87%105.33B | -0.44%125.22B | 1.95%105.14B | -0.25%121.86B | 4.80%107.33B | 3.97%125.77B | 9.06%103.13B |
Non-controlling interest | -1.13%74.21B | -0.51%73.02B | -2.20%71.67B | -3.42%70.35B | 12.33%75.06B | 13.08%73.39B | 15.48%73.29B | 21.28%72.84B | 9.16%66.82B | 3.58%64.91B |
Total equity | -4.74%190.79B | -2.21%189.76B | -0.82%193.55B | -1.26%193.51B | 3.99%200.27B | 3.51%194.04B | 5.13%195.15B | 9.32%195.99B | 5.72%192.59B | 5.89%187.46B |
Total equity and total liabilities | -1.23%501.81B | -0.78%499.67B | 0.39%503.24B | -0.09%488.9B | 2.51%508.06B | 3.65%503.61B | 3.72%501.29B | 5.46%489.34B | -1.53%495.63B | -0.63%485.86B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.